Kaundinya Ganesh Venkataraman 4
4 · MOMENTA PHARMACEUTICALS INC · Filed Feb 14, 2018
Insider Transaction Report
Form 4
Venkataraman Ganesh
Senior V.P., Research
Transactions
- Exercise/Conversion
Common Stock
2018-02-12$7.41/sh+10,103$74,863→ 501,031 total - Sale
Common Stock
2018-02-12$16.20/sh−341$5,524→ 500,690 total - Sale
Common Stock
2018-02-14$15.16/sh−4,645$70,418→ 496,045 total - Award
Restricted Stock Units
2018-02-12−50,000→ 50,000 total→ Common Stock (50,000 underlying) - Exercise/Conversion
Stock Option (Right to Buy)
2018-02-12$7.41/sh+10,103$74,863→ 0 totalExercise: $7.41From: 2012-02-22Exp: 2018-02-22→ Common Stock (10,103 underlying)
Footnotes (3)
- [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan.
- [F2]Each Restricted Stock Unit represents a contingent right to receive one share of MNTA common stock.
- [F3]Subject to certain criteria, the restricted stock units will vest with respect to 50% of the shares on the first anniversary of the grant date, and the remaining 50% will vest on the second anniversary of the grant date.